Skip to main content
Funded Studies

Djalil Coowar, PhD

Chief Scientific Officer at AxoGlia Therapeutics SA


Associated Grants

  • Modulation of the CD40/CD40-Ligand Neuroinflammation Pathway in Parkinson's Pre-Clinical Models

    2012


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.